Yago Garitaonaindía, Translational Research Fellow at CCIT-DK – National Center for Cancer Immune Therapy of Denmark, shared on X:
“In JAAD, from the Spanish Melanoma Registry, n=365.
Does primary stage matter once melanoma relapses?
- Stage I relapsed latest (median 52 mo)
- But more often with brain mets (OR 4.0)
- And had the shortest mOS: 19.8 vs 43 mo in stage III
Low risk at diagnosis ≠ low risk at relapse.”
Title: Primary Melanoma Stage as a Predictor of Survival in Advanced Disease: Findings from the Spanish Melanoma Registry GEM1801
Authors: Maria Gonzalez-Cao, Susana Puig, José Luis Manzano, Miguel-Ángel Berciano-Guerrero, Ainara Soria, Lourdes Gutiérrez Sanz, Pablo Cerezuela-Fuentes, Guillermo Crespo, Eva Muñoz-Couselo, Teresa Puértolas, Carlos Aguado de la Rosa, Luis Antonio Fernández, Enrique Espinosa, Lorena Bellido, Rafael López Castro, Alberto Cunquero-Tomás, Pablo Ayala de Miguel, Salvador Martín Algarra, Iván Márquez-Rodas
Read the Full Article on Journal of the American Academy of Dermatology
You can also read: Amelanotic Melanoma: The Skin Cancer That Can Be Easy to Miss
